These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13310637)

  • 1. [Investigations on living vaccine against tularemia. I. Mildly pathogenic of Bacterium tularense and their immunologic properties].
    SKRODZKI E; TOMASZUNAS S
    Przegl Epidemiol; 1955; 9(3):199-210. PubMed ID: 13310637
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccination strategies for Francisella tularensis.
    Isherwood KE; Titball RW; Davies DH; Felgner PL; Morrow WJ
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1403-14. PubMed ID: 15919131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.
    Griffin AJ; Crane DD; Wehrly TD; Bosio CM
    Clin Vaccine Immunol; 2015 Jan; 22(1):119-28. PubMed ID: 25410207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory and oral vaccination improves protection conferred by the live vaccine strain against pneumonic tularemia in the rabbit model.
    Stinson E; Smith LP; Cole KS; Barry EM; Reed DS
    Pathog Dis; 2016 Oct; 74(7):. PubMed ID: 27511964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on protection against experimental tularemia in mice. II. Immunogenicity of Bacterium tularense filtrates in mice and enhancement by Hemophilus pertussis vaccine.
    PANNELL L
    J Infect Dis; 1958; 102(2):167-73. PubMed ID: 13525776
    [No Abstract]   [Full Text] [Related]  

  • 8. The tularaemia vaccine.
    Sandström G
    J Chem Technol Biotechnol; 1994 Apr; 59(4):315-20. PubMed ID: 7764815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Francisella tularensis vaccines.
    Griffin KF; Oyston PC; Titball RW
    FEMS Immunol Med Microbiol; 2007 Apr; 49(3):315-23. PubMed ID: 17316369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response in mice after vaccination with Bacterium tularense.
    RUCHMAN I; FOSHAY L
    J Immunol Virus Res Exp Chemother; 1949 Mar; 61(3):229-34. PubMed ID: 18117859
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tularemia vaccine strain is a potential vector].
    Pavlov VM; Mokrievich AN; Noskov AN; Urakov NN
    Vestn Ross Akad Med Nauk; 1997; (6):30-2. PubMed ID: 9289276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of allergic reaction to living tularemia vaccine].
    BELOSTOTSKAIA EN; MAKSIMOVA EB; MASHKILLEISON AL
    Zh Mikrobiol Epidemiol Immunobiol; 1955 Jan; 1():97-8. PubMed ID: 14360676
    [No Abstract]   [Full Text] [Related]  

  • 13. Vaccines against Francisella tularensis.
    Wayne Conlan J; Oyston PC
    Ann N Y Acad Sci; 2007 Jun; 1105():325-50. PubMed ID: 17395730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A.
    Wu TH; Hutt JA; Garrison KA; Berliba LS; Zhou Y; Lyons CR
    Infect Immun; 2005 May; 73(5):2644-54. PubMed ID: 15845466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
    Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
    Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice sublethally infected with Francisella novicida U112 develop only marginal protective immunity against systemic or aerosol challenge with virulent type A or B strains of F. tularensis.
    Shen H; Chen W; Conlan JW
    Microb Pathog; 2004 Aug; 37(2):107-10. PubMed ID: 15312850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion and retention of pulmonary CD4
    Roberts LM; Wehrly TD; Crane DD; Bosio CM
    Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung.
    Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O
    Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence of Bacterium tularense. II. Evaluation of criteria of virulence of Bacterium tularense.
    OWEN CR; BELL JF; LARSON CL; ORMSBEE RA
    J Infect Dis; 1955; 97(2):167-76. PubMed ID: 13263646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.